 Ricka Messer
Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anticonvulsants | 2 | 2020 | 216 | 0.890 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2020 | 142 | 0.780 |
Why?
| | Spasms, Infantile | 2 | 2020 | 122 | 0.720 |
Why?
| | Glucocorticoids | 2 | 2020 | 596 | 0.590 |
Why?
| | Neurology | 3 | 2023 | 114 | 0.520 |
Why?
| | Craniocerebral Trauma | 2 | 2025 | 167 | 0.410 |
Why?
| | Receptors, GABA-B | 1 | 2012 | 11 | 0.380 |
Why?
| | Benzoxazines | 1 | 2012 | 31 | 0.380 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1577 | 0.370 |
Why?
| | Naphthalenes | 1 | 2012 | 60 | 0.370 |
Why?
| | CA1 Region, Hippocampal | 1 | 2012 | 52 | 0.370 |
Why?
| | Morpholines | 1 | 2012 | 121 | 0.360 |
Why?
| | Cannabinoids | 1 | 2012 | 161 | 0.320 |
Why?
| | Child Abuse | 2 | 2025 | 546 | 0.310 |
Why?
| | Epilepsy | 1 | 2012 | 332 | 0.280 |
Why?
| | Migraine Disorders | 1 | 2025 | 103 | 0.210 |
Why?
| | Internship and Residency | 2 | 2023 | 1137 | 0.200 |
Why?
| | Neurodevelopmental Disorders | 1 | 2025 | 177 | 0.190 |
Why?
| | Neurotransmitter Uptake Inhibitors | 1 | 2021 | 2 | 0.180 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2021 | 12 | 0.180 |
Why?
| | Brain Injuries | 1 | 2025 | 493 | 0.160 |
Why?
| | Glasgow Coma Scale | 3 | 2025 | 182 | 0.160 |
Why?
| | Brain Diseases | 1 | 2021 | 141 | 0.160 |
Why?
| | Prednisolone | 1 | 2019 | 83 | 0.160 |
Why?
| | Enterovirus | 1 | 2019 | 86 | 0.150 |
Why?
| | Antidepressive Agents | 1 | 2021 | 235 | 0.150 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 358 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2025 | 652 | 0.140 |
Why?
| | Bipolar Disorder | 1 | 2021 | 264 | 0.140 |
Why?
| | Infant | 6 | 2025 | 9451 | 0.140 |
Why?
| | Critical Illness | 1 | 2023 | 808 | 0.140 |
Why?
| | Enterovirus Infections | 1 | 2019 | 177 | 0.130 |
Why?
| | Nervous System Diseases | 1 | 2019 | 265 | 0.130 |
Why?
| | Pregnancy Complications | 1 | 2021 | 525 | 0.120 |
Why?
| | Child, Preschool | 7 | 2025 | 11080 | 0.110 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2054 | 0.100 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2021 | 844 | 0.100 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2012 | 8 | 0.100 |
Why?
| | Organ Culture Techniques | 1 | 2012 | 156 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3568 | 0.090 |
Why?
| | Drug Resistance | 1 | 2012 | 169 | 0.090 |
Why?
| | Mice, Inbred Strains | 1 | 2012 | 409 | 0.090 |
Why?
| | Hypertension | 1 | 2019 | 1285 | 0.080 |
Why?
| | Humans | 13 | 2025 | 137294 | 0.080 |
Why?
| | Child | 5 | 2025 | 21999 | 0.060 |
Why?
| | Male | 8 | 2025 | 67560 | 0.060 |
Why?
| | Diffuse Axonal Injury | 1 | 2023 | 8 | 0.050 |
Why?
| | Female | 8 | 2025 | 73052 | 0.050 |
Why?
| | Corpus Callosum | 1 | 2023 | 70 | 0.050 |
Why?
| | White Matter | 1 | 2023 | 145 | 0.050 |
Why?
| | North America | 1 | 2022 | 313 | 0.050 |
Why?
| | Canada | 1 | 2022 | 421 | 0.040 |
Why?
| | Venlafaxine Hydrochloride | 1 | 2021 | 14 | 0.040 |
Why?
| | Quetiapine Fumarate | 1 | 2021 | 23 | 0.040 |
Why?
| | Bupropion | 1 | 2021 | 45 | 0.040 |
Why?
| | Pneumococcal Infections | 1 | 2001 | 115 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2001 | 142 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 5769 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2025 | 15639 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4527 | 0.040 |
Why?
| | Causality | 1 | 2019 | 127 | 0.040 |
Why?
| | Bacteremia | 1 | 2001 | 211 | 0.040 |
Why?
| | Hormones | 1 | 2019 | 142 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 503 | 0.040 |
Why?
| | Emotions | 1 | 2023 | 547 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2021 | 1063 | 0.040 |
Why?
| | Age Factors | 1 | 2025 | 3297 | 0.030 |
Why?
| | Communication | 1 | 2023 | 879 | 0.030 |
Why?
| | Disease Outbreaks | 1 | 2019 | 384 | 0.030 |
Why?
| | Incidence | 2 | 2019 | 2808 | 0.030 |
Why?
| | Family | 1 | 2020 | 666 | 0.030 |
Why?
| | Registries | 1 | 2023 | 2016 | 0.030 |
Why?
| | Prognosis | 1 | 2023 | 4026 | 0.030 |
Why?
| | Adolescent | 2 | 2025 | 21499 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1624 | 0.030 |
Why?
| | Mice | 1 | 2012 | 17774 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1623 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5436 | 0.030 |
Why?
| | Risk Factors | 2 | 2025 | 10368 | 0.030 |
Why?
| | Animals | 1 | 2012 | 36862 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6054 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 13163 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 6743 | 0.020 |
Why?
| | United States | 1 | 2025 | 14742 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10800 | 0.010 |
Why?
| | Queensland | 1 | 2001 | 48 | 0.010 |
Why?
| | Vaccines, Conjugate | 1 | 2001 | 65 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2001 | 330 | 0.010 |
Why?
| | Age Distribution | 1 | 2001 | 391 | 0.010 |
Why?
| | Sex Distribution | 1 | 2001 | 376 | 0.010 |
Why?
| | Rural Population | 1 | 2001 | 563 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2001 | 2836 | 0.010 |
Why?
| | Vaccination | 1 | 2001 | 1379 | 0.010 |
Why?
| | Cohort Studies | 1 | 2001 | 5726 | 0.010 |
Why?
|
|
Messer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|